4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
bioMérieux S.A. (BIM) operates in the Diagnostics & Research industry and is headquartered in Marcy-l'Étoile, France with about 14,562 employees. Its market capitalization is roughly €9 billion. In the fiscal year ended 2025-12-31, BIM reported €4.1B in revenue and €398M in net income.
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €4.1B | €4.0B | €3.7B | €3.6B | — |
| Gross Profit | €2.3B | €2.2B | €2.1B | €2.0B | — |
| Operating Income (EBIT) | €695M | €638M | €569M | €626M | — |
| Net Income | €398M | €432M | €358M | €452M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€106M) | (€100M) | (€100M) | (€101M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €5.6B | €5.8B | €5.3B | €5.2B | — |
| Total Liabilities | €1.5B | €1.6B | €1.5B | €1.5B | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIM viewer.
About TickerBase · Data methodology & sources · Privacy · Terms